3 studies found for: Open Studies | Myocardial Ischemia | UCSD OR UC San Diego OR VA San Diego
Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Cardiovascular Inflammation Reduction Trial
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
† Study has passed its completion date and status has not been verified in more than two years.